Información de la revista
Vol. 100. Núm. 1.
Páginas 3-6 (enero - febrero 2009)
Vol. 100. Núm. 1.
Páginas 3-6 (enero - febrero 2009)
Opinion article
Acceso a texto completo
Narrowband Ultraviolet B Therapy in Psoriasis: Reality, Outlook, and Uncertainty
Visitas
6474
J.M. Carrascosa
Autor para correspondencia
jmcarrascosac@hotmail.com
Correspondence: Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Crta. del Canyet s/n, 08916 Badalona, Barcelona, Spain.
Correspondence: Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Crta. del Canyet s/n, 08916 Badalona, Barcelona, Spain.
Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
References
[1.]
J.A. Parrish, K.F. Jaenicke.
Action spectrum for phototherapy of psoriasis.
J Invest Dermatol, 76 (1981), pp. 359-362
[2.]
T. Fisher.
UV-light treatment of psoriasis.
Acta Derm Venereol (Stockh), 56 (1976), pp. 473-479
[3.]
R.S. Dawe.
A quantitative review of studies comparing the efficacy of narrow-band and broad-band ultraviolet B for psoriasis.
Br J Dermatol, 149 (2003), pp. 655-668
[4.]
A. Tanew, S. Radakovic-Fijan, M. Schemper, H. Hönigsmann.
Narrow-band UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis. A paired comparison study.
Arch Dermatol, 135 (1999), pp. 519-524
[5.]
S.H. Ibbotson, D. Bilsland, N.H. Cox, R.S. Dawe, B. Diffey, C. Edwards.
An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report.
Br J Dermatol, 151 (2004), pp. 283-297
[6.]
J.M. Carrascosa.
Fototerapia y fotoquimioterapia.
Actas Dermosifiliogr, 95 (2004), pp. 259-284
[7.]
J.M. Carrascosa, X. Bigatà.
UVB terapia de banda estrecha: experiencia en la práctica clínica y factores predictivos de respuesta.
Actas Dermosifiliogr, 91 (2000), pp. 555-562
[8.]
R.S. Dawe, N.J. Wainwright, H. Cameron, J. Ferguson.
Narrow-band (TL-01) ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment?.
Br J Dermatol, 138 (1998), pp. 833-839
[9.]
B.L. Diffey.
Investigative report. Towards optimal regimens for the UVB phototherapy of psoriasis: A mathematical model.
Acta Derm Venereol, 84 (2004), pp. 259-264
[10.]
G. Boztepe, H. Akinci, S. Sahin, A. Karaduman, S.E. Evans, G. Erkin, et al.
In search of an optimum dose escalation for narrowband UVB phototherapy: Is it time to quit 20% increments?.
J Am Acad Dermatol, 55 (2006), pp. 269-271
[11.]
G. Gökdemir, I. Kivanç-Altunay, A. Köslü.
Narrow-band ultraviolet B phototherapy in patients with psoriasis: for which types of psoriasis is it more effective?.
Br J Dermatol, 32 (2005), pp. 436-441
[12.]
P. Calzavara-Pinton, G. Leone, M. Venturini, R. Sala, D. Colombo, I.L. La Parola, et al.
A comparative non randomized study of narrow-band (NB) (312±2nm) UVB phototherapy versus sequential therapy with oral administration of low-dose Cyclosporin A and NB-UVB phototherapy in patients with severe psoriasis vulgaris.
Eur J Dermatol, 15 (2005), pp. 470-473
[13.]
B.L. Diffey.
Factors affecting the choice of a ceiling on the number of exposures with TL01 ultraviolet B phototherapy.
Br J Dermatol, 149 (2003), pp. 428-430
[14.]
M. Weischer, A. Blum, F. Eberhard, M. Röcken, M. Berneburg.
No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study.
Acta Derm Venereol, 84 (2004), pp. 370-374
[15.]
H. Cameron, S. Yule, H. Moseley, R.S. Dawe, J. Ferguson.
Taking treatment to the patient: development of a home TL-01 ultraviolet B phototherapy service.
Br J Dermatol, 147 (2002), pp. 957-965
[16.]
S.M. Langan, A. Heerey, M. Barry, L. Barnes.
Cost analysis of narrowband UVB phototherapy in psoriasis.
J Am Acad Dermatol, 50 (2004), pp. 623-626
[17.]
J.F. Simpson, C.B. Yelverton, R. Balkrishnan, A. Fleischer Jr, W. Lide, S.R. Feldman.
Would elimination of copayments for phototherapy decrease the cost of treating psoriasis with systemic biologics? A cost analysis.
Manag Care Interface, 19 (2006), pp. 39-43
[18.]
J.M. Carrascosa, X. Soria, C. Ferrándiz.
Effective management of a psoriatic flare with narrowband UVB phototherapy during efalizumab therapy without discontinuing treatment.
J Eur Acad Dermatol Venereol, 21 (2007), pp. 828-829
[19.]
J.P. Ortonne, A. Khemis, J.Y. Koo, J. Choi.
An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis.
J Eur Acad Dermatol Venereol, 19 (2005), pp. 556-563
[20.]
L. Kircik, J. Bagel, N. Korman, A. Menter, C.A. Elmets, J. Koo, Unite Study Group, et al.
Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes.
J Drugs Dermatol, 7 (2008), pp. 245-253
[21.]
M.T. Rodríguez-Granados, J.M. Carrascosa, T. Gárate, S. Gómez-Díez, D. Guimaraens-Juantorena.
Documento de consenso sobre la modalidad terapéutica del baño-PUVA.
Actas Dermosifiliogr, 98 (2007), pp. 164-170
[22.]
J.M. Carrascosa, J. Gardeazábal, A. Pérez-Ferriols, A. Alomar, P. Manrique, M. Jones-Caballero, et al.
Grupo Español de Fotobiología Documento de consenso sobre fototerapia: terapias PUVA y UVB de banda estrecha.
Actas Dermosifiliogr, 96 (2005), pp. 635-658
[24.]
S.M. Kirke, S. Lowder, J.J. Lloyd, B.L. Diffey, J.N. Matthews, P.M. Farr.
A randomized comparison of selective broadband UVB and narrowband UVB in the treatment of psoriasis.
J Invest Dermatol, 127 (2007), pp. 1570-1571
Copyright © 2009. Academia Española de Dermatología y Venereología and Elsevier España, S.L.